Skip to main content
Equibles
KYNB $8.49 -0.47%
KYNB logo
KYNB · Kyntra Bio, Inc.
Track KYNB — free

Use KYNB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$8.49 -0.04 (-0.47%) At close · Sep 3
Rebalance outlook locked
Market Cap
$34.01M
Shares
4.05M
All earnings calls

Earnings call · FY2022 Q3

Kyntra Bio, Inc. (KYNB) Q3 2022 Earnings Call

Concluded Nov 7, 2022
Nov 7, 2022 0 turns
Period
FY2022 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $15.73M -89.9% YoY
Diluted EPS -$24.50 -281.5% YoY
Net income -$91.65M -284% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 7, 2022 10-Q report Filed Nov 7, 2022

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$17.36M +29.1% YoY
Development and Other Revenue$2.45M -90.6% YoY
License$0 -100% YoY
Drug Product Revenue-$4.08M
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)